1 unread notifications

Martin Borch Jensen is a co-founder and chief scientific officer of Gordian Biotechnology, where he applies pooled in vivo screening to age-related disease. He also founded Norn Group to build the research funding, talent, benchmarks, and infrastructure needed to industrialize longevity.

Unclaimed profile

Martin Borch Jensen is a co-founder and chief scientific officer of Gordian Biotechnology, where he applies pooled in vivo screening to age-related disease. He also founded Norn Group to build the research funding, talent, benchmarks, and infrastructure needed to industrialize longevity.

Career

Martin Borch Jensen holds a PhD from University of Copenhagen.

Founder and President at Norn Group from 2021 to Present
Co-founder and Chief Scientific Officer at Gordian Biotechnology from 2018 to Present
Postdoctoral Researcher at Buck Institute for Research on Aging from 2013 to 2018

Cosigns Received

These Cosigners would work with Martin anywhere

norngroup.substack.com

Ask not what AI can do for longevity

Martin argues that AI will only accelerate longevity medicine if the field deliberately creates task-shaped biological data and verifiable outcomes.

Open ↗
norngroup.substack.com

Do we have a useful aging clock?

A practical assessment of aging biomarkers, why existing clocks do not yet shorten trials, and what validation work is still missing.

Open ↗

Martin's Collections

Martin's Lists

In these lists

Cosigns Given